A prospective cohort study is conducted to evaluate a new low-molecular-weight heparin (LMWH) protocol versus standard unfractionated heparin (UFH) for deep vein thrombosis (DVT) prophylaxis in high-risk pregnant women. The study follows 2,000 women from the first trimester through the postpartum period. The primary endpoint, incidence of symptomatic DVT, occurs in 20 women in the LMWH group and 40 women in the UFH group. The unadjusted relative risk is 0.50 (95% CI: 0.29 - 0.85; ). A secondary analysis stratifies the participants by maternal age. In women under 35 years old, the relative risk is 0.48 (95% CI: 0.22 - 1.05; ). In women 35 years and older, the relative risk is 0.52 (95% CI: 0.25 - 1.08; ). Routine third-trimester laboratory results for the cohort show a mean hemoglobin of 10.8 g/dL and hematocrit of 32%. Which of the following statements represents the most accurate interpretation of this study's findings?
- The loss of statistical significance in the age-stratified subgroups is most likely due to a Type II error resulting from reduced sample size.Answer
- BThe stratified analysis demonstrates that maternal age acts as a significant effect modifier on the efficacy of the LMWH protocol.
- CThe case-control design of this study prevents the direct calculation of DVT incidence, limiting the validity of the relative risk.
- DIf a diagnostic test for DVT used in this study is applied to a lower-risk general obstetric population, its positive predictive value will increase.
- EThe third-trimester laboratory findings indicate pathological anemia in this cohort, representing an adverse effect that requires medical intervention.